We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$1.89B
AUM Growth
-$7.83M
(-0.41%)
Cap. Flow
-$104M
Cap. Flow
% of AUM
-5.5%
Top 10 Holdings %
Top 10 Hldgs %
9.2%
Holding
825
New
253
Increased
155
Reduced
199
Closed
218
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Workday
WDAY
|
+$19.2M |
| 2 |
Beyond Meat
BYND
|
+$18.9M |
| 3 |
Ulta Beauty
ULTA
|
+$15.6M |
| 4 |
Motorola Solutions
MSI
|
+$15.4M |
| 5 |
NXP Semiconductors
NXPI
|
+$14.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$19.2M |
| 2 |
Dollar General
DG
|
+$19M |
| 3 |
Nike
NKE
|
+$18.4M |
| 4 |
Citigroup
C
|
+$18.3M |
| 5 |
Palo Alto Networks
PANW
|
+$17.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.38% |
| 2 | Consumer Discretionary | 12.99% |
| 3 | Healthcare | 12.8% |
| 4 | Industrials | 10.78% |
| 5 | Financials | 10.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Adaptive Biotechnologies
ADPT
$3.85B
| $209K | 0.01% |
+7,000
| New | +$201K |
|
|
SYNH
602
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $207K | 0.01% |
3,480
-8,400
| -71% | -$452K |
|
603
SLM Corp
SLM
$4.86B
| $202K | 0.01% |
22,641
-14,859
| -40% | -$129K |
|
604
FMC
FMC
$1.48B
| $201K | 0.01% |
2,012
-16,900
| -89% | -$1.57M |
|
605
Telefônica Brasil
VIV
$20.6B
| $185K | 0.01% |
+13,100
| New | +$175K |
|
606
Banco Bilbao Vizcaya Argentaria
BBVA
$152B
| $129K | 0.01% |
+23,200
| New | +$124K |
|
607
Infosys
INFY
$48.4B
| $128K | 0.01% |
+12,408
| New | +$125K |
|
|
ACB
608
Aurora Cannabis
ACB
$175M
| – | – |
-106
| Closed | -$56K |
|
609
Accenture
ACN
$99.9B
| – | – |
-29,400
| Closed | -$5.66M |
|
610
Automatic Data Processing
ADP
$105B
| – | – |
-65,520
| Closed | -$10.6M |
|
611
Agios Pharmaceuticals
AGIO
$1.95B
| – | – |
-7,186
| Closed | -$233K |
|
612
Align Technology
ALGN
$12.4B
| – | – |
-23,814
| Closed | -$4.31M |
|
613
Alnylam Pharmaceuticals
ALNY
$27.5B
| – | – |
-6,684
| Closed | -$538K |
|
614
Antero Midstream
AM
$10.2B
| – | – |
-108,630
| Closed | -$804K |
|
615
Ambarella
AMBA
$3.25B
| – | – |
-35,300
| Closed | -$2.22M |
|
616
Amgen
AMGN
$209B
| – | – |
-27,813
| Closed | -$5.38M |
|
617
AutoNation
AN
$7.18B
| – | – |
-19,202
| Closed | -$974K |
|
618
A.O. Smith
AOS
$8.24B
| – | – |
-24,347
| Closed | -$1.16M |
|
619
Aramark
ARMK
$15.1B
| – | – |
-123,118
| Closed | -$3.87M |
|
620
ATI
ATI
$24.8B
| – | – |
-16,554
| Closed | -$335K |
|
|
OPTU
621
Optimum Communications Inc
OPTU
$290M
| – | – |
-187,171
| Closed | -$5.37M |
|
622
AngloGold Ashanti
AU
$41.6B
| – | – |
-39,000
| Closed | -$713K |
|
623
Avient
AVNT
$3.36B
| – | – |
-38,500
| Closed | -$1.26M |
|
624
American Water Works
AWK
$27.2B
| – | – |
-18,196
| Closed | -$2.26M |
|
625
Acuity Brands
AYI
$10.1B
| – | – |
-1,500
| Closed | -$202K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Seven Eight Capital held 825 positions worth $1.89B, down 0.41% from $1.89B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
Seven Eight Capital withdrew a net $104M in Q4 2019, closing 218 positions and reducing 199 holdings. Its most notable exit was UnitedHealth, an estimated $19.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Seven Eight Capital opened a new position in Workday worth $19M.
- Seven Eight Capital's largest Q4 2019 buy was Workday: 115,611 shares worth $19M.
- Seven Eight Capital added most to Motorola Solutions in Q4 2019, an estimated $15.4M increase.
- Seven Eight Capital's biggest Q4 2019 reduction was Citigroup, cutting an estimated $18.3M.
- Seven Eight Capital fully exited UnitedHealth in Q4 2019, selling an estimated $19.2M.
- Seven Eight Capital's ten largest holdings make up 9.2% of its $1.89B portfolio in Q4 2019.
- Seven Eight Capital opened 253 new positions and closed 218 in Q4 2019.
- Seven Eight Capital's portfolio value fell 0.41% quarter-over-quarter to $1.89B.
Based on Seven Eight Capital's 13F filing for Q4 2019, filed 13 Feb 2020.